These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 23826993)
1. Combinatorial molecular marker assays of WT1, survivin, and TERT at initial diagnosis of adult acute myeloid leukemia. Kim HJ; Choi EJ; Sohn HJ; Park SH; Min WS; Kim TG Eur J Haematol; 2013 Nov; 91(5):411-22. PubMed ID: 23826993 [TBL] [Abstract][Full Text] [Related]
2. Wilms' tumor gene 1 transcript levels in leukapheresis of peripheral blood hematopoietic cells predict relapse risk in patients autografted for acute myeloid leukemia. Messina C; Candoni A; Carrabba MG; Tresoldi C; Sala E; Tassara M; Crippa A; Peccatori J; Assanelli A; Gattillo S; Bellio L; Fanin R; Ciceri F; Bernardi M Biol Blood Marrow Transplant; 2014 Oct; 20(10):1586-91. PubMed ID: 24954546 [TBL] [Abstract][Full Text] [Related]
3. Reduction in WT1 gene expression during early treatment predicts the outcome in patients with acute myeloid leukemia. Andersson C; Li X; Lorenz F; Golovleva I; Wahlin A; Li A Diagn Mol Pathol; 2012 Dec; 21(4):225-33. PubMed ID: 23111196 [TBL] [Abstract][Full Text] [Related]
4. Serial measurement of WT1 expression and decrement ratio until hematopoietic cell transplantation as a marker of residual disease in patients with cytogenetically normal acute myelogenous leukemia. Yoon JH; Kim HJ; Shin SH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW; Lim JH Biol Blood Marrow Transplant; 2013 Jun; 19(6):958-66. PubMed ID: 23542687 [TBL] [Abstract][Full Text] [Related]
5. BAALC and WT1 expressions from diagnosis to hematopoietic stem cell transplantation: consecutive monitoring in adult patients with core-binding-factor-positive AML. Yoon JH; Kim HJ; Shin SH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW; Lim JH Eur J Haematol; 2013 Aug; 91(2):112-21. PubMed ID: 23672350 [TBL] [Abstract][Full Text] [Related]
6. Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study. Cilloni D; Renneville A; Hermitte F; Hills RK; Daly S; Jovanovic JV; Gottardi E; Fava M; Schnittger S; Weiss T; Izzo B; Nomdedeu J; van der Heijden A; van der Reijden BA; Jansen JH; van der Velden VH; Ommen H; Preudhomme C; Saglio G; Grimwade D J Clin Oncol; 2009 Nov; 27(31):5195-201. PubMed ID: 19752335 [TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of Wilms' tumor gene (WT1) expression in patients with de novo acute myeloid leukemia. Barragán E; Cervera J; Bolufer P; Ballester S; Martín G; Fernández P; Collado R; Sayas MJ; Sanz MA Haematologica; 2004 Aug; 89(8):926-33. PubMed ID: 15339675 [TBL] [Abstract][Full Text] [Related]
8. Detectable Wilms' tumor-1 transcription at treatment completion is associated with poor prognosis of acute myeloid leukemia: a single institution's experience. Yamauchi T; Negoro E; Lee S; Takai M; Matsuda Y; Takagi K; Kishi S; Tai K; Hosono N; Tasaki T; Ikegaya S; Yoshida A; Urasaki Y; Iwasaki H; Ueda T Anticancer Res; 2013 Aug; 33(8):3335-40. PubMed ID: 23898100 [TBL] [Abstract][Full Text] [Related]
9. Monitoring of minimal residual disease by quantitative WT1 gene expression following reduced intensity conditioning allogeneic stem cell transplantation in acute myeloid leukemia. Candoni A; Toffoletti E; Gallina R; Simeone E; Chiozzotto M; Volpetti S; Fanin R Clin Transplant; 2011; 25(2):308-16. PubMed ID: 20412098 [TBL] [Abstract][Full Text] [Related]
10. Simultaneous in vitro generation of CD8 and CD4 T cells specific to three universal tumor associated antigens of WT1, survivin and TERT and adoptive T cell transfer for the treatment of acute myeloid leukemia. Sohn HJ; Lee JY; Lee HJ; Sohn DH; Cho HI; Kim HJ; Kim TG Oncotarget; 2017 Jul; 8(27):44059-44072. PubMed ID: 28477011 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of minimal residual disease by real-time quantitative PCR of Wilms' tumor 1 expression in patients with acute myelogenous leukemia after allogeneic stem cell transplantation: correlation with flow cytometry and chimerism. Kwon M; Martínez-Laperche C; Infante M; Carretero F; Balsalobre P; Serrano D; Gayoso J; Pérez-Corral A; Anguita J; Díez-Martín JL; Buño I Biol Blood Marrow Transplant; 2012 Aug; 18(8):1235-42. PubMed ID: 22281301 [TBL] [Abstract][Full Text] [Related]
12. Expression of Wilms' tumor gene 1 at different stages of acute myeloid leukemia and analysis of its major splice variants. Siehl JM; Reinwald M; Heufelder K; Menssen HD; Keilholz U; Thiel E Ann Hematol; 2004 Dec; 83(12):745-50. PubMed ID: 15340762 [TBL] [Abstract][Full Text] [Related]
13. Quantitative real-time RT-PCR detects elevated Wilms tumor gene (WT1) expression in autologous blood stem cell preparations (PBSCs) from acute myeloid leukemia (AML) patients indicating contamination with leukemic blasts. Siehl JM; Thiel E; Leben R; Reinwald M; Knauf W; Menssen HD Bone Marrow Transplant; 2002 Mar; 29(5):379-81. PubMed ID: 11919726 [TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia. Candoni A; Tiribelli M; Toffoletti E; Cilloni D; Chiarvesio A; Michelutti A; Simeone E; Pipan C; Saglio G; Fanin R Eur J Haematol; 2009 Jan; 82(1):61-8. PubMed ID: 18801058 [TBL] [Abstract][Full Text] [Related]
15. Significant co-expression of WT1 and MDR1 genes in acute myeloid leukemia patients at diagnosis. Galimberti S; Guerrini F; Carulli G; Fazzi R; Palumbo GA; Morabito F; Petrini M Eur J Haematol; 2004 Jan; 72(1):45-51. PubMed ID: 14962262 [TBL] [Abstract][Full Text] [Related]
16. [Significance of dynamic detection of WT1 expression on monitoring minimal residual disease in leukemia patients following allogeneic bone marrow transplantation]. Gu WY; Chen ZX; Hu SY; Zhu J; Wang ZL; Yan F; Wang W; Cen JN; Shen HL; Qian J Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):444-7. PubMed ID: 15854547 [TBL] [Abstract][Full Text] [Related]
17. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring. Boublikova L; Kalinova M; Ryan J; Quinn F; O'Marcaigh A; Smith O; Browne P; Stary J; McCann SR; Trka J; Lawler M Leukemia; 2006 Feb; 20(2):254-63. PubMed ID: 16341043 [TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of Wilms tumor gene mutations in Egyptian patients with acute myeloid leukemia with normal karyotype. Zidan MA; Kamal Shaaban HM; Elghannam DM Hematology; 2014 Jul; 19(5):267-74. PubMed ID: 24074521 [TBL] [Abstract][Full Text] [Related]
19. Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation. Qin YZ; Wang Y; Zhu HH; Gale RP; Zhang MJ; Jiang Q; Jiang H; Xu LP; Chen H; Zhang XH; Liu YR; Lai YY; Jiang B; Liu KY; Huang XJ Chin J Cancer; 2016 May; 35():46. PubMed ID: 27197573 [TBL] [Abstract][Full Text] [Related]
20. Quantitative monitoring of WT1 expression in peripheral blood before and after allogeneic stem cell transplantation for acute myeloid leukemia - a useful tool for early detection of minimal residual disease. Polak J; Hajkova H; Haskovec C; Cechova H; Marinov I; Mikulenkova D; Markova J; Markova M; Vitek A; Valkova V Neoplasma; 2013; 60(1):74-82. PubMed ID: 23067220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]